Relay Therapeutics (RLAY) Shares Outstanding (Diluted Average) (2021 - 2022)
Relay Therapeutics (RLAY) reported Shares Outstanding (Diluted Average) of $109.3 million for Q3 2022, up 17.91% year-over-year from $92.7 million in Q3 2021, and up 17.91% quarter-over-quarter from $92.7 million in Q3 2021.
Relay Therapeutics (RLAY) Shares Outstanding (Diluted Average) (2021 - 2022) Analysis & Trends
Relay Therapeutics (RLAY) has 2 years of Shares Outstanding (Diluted Average) data on file, last reported at $109.3 million in Q3 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 4,489.46 Bn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 810.00 |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 118.76 Bn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 1.48 Bn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 256.30 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 92.44 Mn |
| 10 | Relay Therapeutics | 2.86 Bn | 2.86 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 109.29 Mn |
| Sep 30, 2021 | 92.69 Mn |